Sitagliptin ameliorates lipid profile changes and endothelium dysfunction induced by atherogenic diet in rabbits

Sitagliptin exerts anti-inflammatory and anti-allergic effects in ovalbumin-induced murine model of allergic airway disease

(2013) Manar A. Nader et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells

(2012) Aya Shiraki et al.   ATHEROSCLEROSIS

The effect of glucagon-like peptide 1 on cardiovascular risk

(2012) Jacob Sivertsen et al.   Nature Reviews Cardiology

Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells

(2011) Li Ding et al.   ACTA PHARMACOLOGICA SINICA

Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states

(2011) Sarah Farr et al.   CURRENT OPINION IN LIPIDOLOGY

Inhibition of anaphylaxis like reaction and mast cell activation by Sitagliptin

(2011) Manar A. Nader   INTERNATIONAL IMMUNOPHARMACOLOGY

Effect of Enhanced Glycemic Control with Saxagliptin on Endothelial Nitric Oxide Release and CD40 Levels in Obese Rats

(2011) R. Preston Mason et al.   Journal of Atherosclerosis and Thrombosis

Pomegranate Fruit Extract Inhibits UVB-induced Inflammation and Proliferation by Modulating NF-κB and MAPK Signaling Pathways in Mouse Skin†

(2011) Naghma Khan et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits

(2010) Manar A. Nader et al.   ARCHIVES OF PHARMACAL RESEARCH

Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species–Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A

(2010) Hisko Oeseburg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dipeptydil peptidase-4 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials

(2009) M. Monami et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

(2008) Kiwon Ban et al.   CIRCULATION

Sitagliptin Augments Sympathetic Enhancement of the Renovascular Effects of Angiotensin II in Genetic Hypertension

(2008) Edwin K. Jackson et al.   HYPERTENSION

Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk

(2008) E. Mannucci et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: Role of cyclooxygenase metabolites

(2007) Susana Jerez et al.   EUROPEAN JOURNAL OF PHARMACOLOGY